Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : The Fraud of Biological Psychiatry -- Ignore unavailable to you. Want to Upgrade?

To: IEarnedIt who wrote (188)	9/14/2000 12:02:21 PM
From: Don Pueblo	Read Replies (1) \| Respond to of 444

Trouble for Ritalin manufacturer... I love it. ++++++++++++++ Thursday September 14, 5:01 am Eastern Time Novartis named in two new Ritalin suits-WSJ NEW YORK, Sept 14 (Reuters) - Novartis AG , maker of the drug Ritalin, was named in lawsuits filed in California and New Jersey on behalf of consumers, accusing the Swiss pharmaceuticals group of conspiring with the American Psychiatric Association to ``create'' a disease, the Wall Street Journal reported in its electronic edition on Thursday. Ritalin is used to treat attention-deficit hyper-activity disorder. The cases seek billions of dollars in damages, and are likely to be followed by suits on behalf of consumers in other states, the lawyers told the newspaper. A similar suit was filed in a Texas state court in May. At that time, Novartis said the claims in the suit were without merit. The lawsuits, which seek class-action status, contend that Novartis, its subsidiary Ciba-Geigy, and the psychiatric association, conspired to create a broad-based definition of hyperactivity disorders in the standard medical text used by doctors, the newspaper reported. biz.yahoo.com